SEPANTA as Sponsor at JAM Hospital’s Scientific Conference on Adrenal Tumors

On August 21, 2025, SEPANTA proudly participated as a sponsor in the one-day scientific conference on “Novel Diagnostic and Therapeutic Approaches for Adrenal Tumors” held at Jam Hospital. The conference aimed to advance physicians’ knowledge and introduce the latest diagnostic methods and technologies in the field of adrenal tumors, providing a unique opportunity for experience sharing and exposure to advanced medical equipment.
At the event, the SEPANTA team presented the state-of-the-art UTAB H1 ultrasound system, allowing physicians to familiarize themselves firsthand with its capabilities and performance. Attendees had the opportunity to test the device, experience the high-quality imaging and precision it offers, and observe its user-friendly design and innovative features. This direct interaction provided valuable insights into the device’s ability to support accurate diagnoses and enhance patient care.
The company’s presence at the conference reflects its ongoing commitment to developing innovative medical technologies and providing reliable solutions for the healthcare community. Beyond showcasing the device, the event enabled SEPANTA to engage with specialists in adrenalology and related surgical fields, gather professional feedback, and optimize product development based on real clinical needs.
By participating in such events, SEPANTA strives to push the boundaries of innovation and quality in medical equipment, offering a professional and valuable experience to the medical community. This initiative represents an important step in introducing physicians to advanced technologies and improving the processes of diagnosis and treatment for patients.